Navigation Links
HeartWare Completes Enrollment In 450-Patient Pivotal Destination Therapy Clinical Trial
Date:5/8/2012

eriod extending to five years post implant. 

The primary endpoint of the trial is survival at two years, defined as alive on the originally implanted device without a debilitating stroke, transplanted or explanted due to patient recovery.  Secondary endpoints include adverse events such as bleeding and infection, as well as functional status, hospitalization, assessment of neuro-cognitive function and patient quality of life.  The Company plans to request from the FDA approval to implant additional Destination Therapy patients under a Continued Access Protocol (CAP) in U.S. centers that implanted a patient in the ENDURANCE trial. 

The HeartWare Ventricular Assist System is also under FDA review for a Bridge-to-Transplant indication.  On April 25, 2012, the FDA's Circulatory System Devices Advisory Committee voted 9 to 2 that the benefits outweigh the risks for the use of the HeartWare Ventricular Assist System as a bridge to heart transplantation in patients with end-stage heart failure.  The Advisory Committee's recommendation, while not binding, will be considered by the FDA in its review of the Premarket Approval (PMA) application submitted for the HeartWare Ventricular Assist System in December 2010. 

About HeartWare International

HeartWare International develops and manufactures miniaturized implantable heart pumps, or ventricular assist devices, to treat Class IIIB / IV patients suffering from advanced heart failure.  The HeartWare® Ventricular Assist System features the HVAD® pump, a small full-output circulatory support device (up to 10L/min flow) designed to be implanted next to the heart, avoiding the abdominal surgery generally required to implant competing devices.  HeartWare has received CE Marking for the HeartWare System in the European Union.  The device is currently the subject of United States clinical trials for two indications: Bridge-to-Transplant u
'/>"/>

SOURCE HeartWare International, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. HeartWare Presentation at the Bank of America Merrill Lynch 2012 Health Care Conference to be Webcast
2. Heartware Schedules First Quarter Conference Call And Webcast
3. HeartWare Stock Trading Halted Today; FDA Advisory Committee to Review HeartWare® Ventricular Assist System as a Bridge to Heart Transplantation
4. HeartWare Receives 54-Patient Allotment From FDA Under Continued Access Protocol for Pivotal U.S. Bridge-to-Transplant Clinical Trial
5. HeartWare Presentation At The Barclays Capital 2012 Global Healthcare Conference To Be Webcast
6. HeartWare Schedules Fourth Quarter Conference Call and Webcast
7. HeartWare and Dualis MedTech Announce Agreement to Develop Fully Implantable Ventricular Assist System
8. HeartWare to Present at the Oppenheimer 22nd Annual Healthcare Conference
9. HeartWare to Present at the 23rd Annual Piper Jaffray Health Care Conference
10. HeartWare to Present at the Lazard Capital Markets 8th Annual Healthcare Conference
11. HeartWare to Present at the Credit Suisse 2011 Healthcare Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/23/2013)... 2013 More than half of women diagnosed ... chemotherapy and still have excellent outcomes. To educate women, ... the largest sources of online consumer information about breast ... page provide recently diagnosed women with information sources, to ... "We anticipate these innovative social media campaigns ...
(Date:5/23/2013)... , May 23, 2013  Hologic, Inc. ... ), a leading developer, manufacturer and supplier of ... with an emphasis on serving the healthcare needs ... observational study in a U.S. clinical practice comparing ... (breast tomosynthesis) with conventional 2D mammography alone showed ...
(Date:5/23/2013)...  BioElectronics Corporation (OTC Pink: BIEL), the maker of ... FDA panel meeting for non-thermal shortwave diathermy: ... Therapy Meeting was held on May 21, 2013 in ... of the meeting was very narrow, in that the ... the application of non-thermal shortwave diathermy for the treatment ...
Breaking Medicine Technology:Agendia Launches Social Media Campaigns to Help Breast Cancer Patients with Chemotherapy Decisions 2Agendia Launches Social Media Campaigns to Help Breast Cancer Patients with Chemotherapy Decisions 3First Large-Scale Population-Based Study in the U.S. Shows Hologic's 3D Mammography (Breast Tomosynthesis) Significantly Reduces Recall Rates While Simultaneously Improving Cancer Detection 2First Large-Scale Population-Based Study in the U.S. Shows Hologic's 3D Mammography (Breast Tomosynthesis) Significantly Reduces Recall Rates While Simultaneously Improving Cancer Detection 3First Large-Scale Population-Based Study in the U.S. Shows Hologic's 3D Mammography (Breast Tomosynthesis) Significantly Reduces Recall Rates While Simultaneously Improving Cancer Detection 4BioElectronics and Pulsed Shortwave Therapy Make Progress 2
(Date:5/24/2013)... commonly used to treat glaucoma may cause droopy eyelids ... according to a new study. The drugs, known ... eye pressure, have already been shown to cause blurred ... said, suggesting that the new findings could lead to ... conservative when prescribing these drugs, the researchers added, particularly ...
(Date:5/24/2013)... New York (PRWEB) May 24, 2013 Let’s ... teeth. It is not uncommon for the majority of people ... Whether it is due to a coffee addiction or simply ... why whitening procedures are so popular. , Herald ... new and very effective whitening system: Venus White Max. ...
(Date:5/24/2013)... 2013 Area homeowners dreaming about owning a ... tubs to choose from at factory-direct pricing during the ... event takes place at Emerald Pool and Patio ... Jacuzzi, the industry's leading hot tub brand, scheduled the event ... The event will feature popular hot tub models at up ...
(Date:5/24/2013)... May 24, 2013 The nation’s first ... Intuitive Surgical Inc.’s da Vinci Surgical System concluded yesterday, ... a Washington State Court jury ruled in a 10-to-2 ... a surgeon who performed a da Vinci prostatectomy on ... patient’s family had alleged in their lawsuit that the ...
(Date:5/24/2013)... infantile myofibromatosis (IM)a disorder characterized by multiple tumors involving ... targets, according to researchers from the Icahn School of ... American Journal of Human Genetics , may lead ... which the only current treatment option is repeated surgical ... disorder that develops in infancy or even in utero ...
Breaking Medicine News(10 mins):Health News:Common Glaucoma Drug May Cause Droopy Eyelids, Study Finds 2Health News:Herald Square Dental Introduces New In-office Whitening System: Venus White Max 2Health News:Truckload of Jacuzzi® Hot Tubs Rolls into Bend, Oregon on May 24, 2013 for Sales Event 2Health News:Da Vinci Robot Lawsuit News: Bernstein Liebhard LLP Comments on Verdict in Nation’s First Trial Involving Alleged Da Vinci Complications 2Health News:Da Vinci Robot Lawsuit News: Bernstein Liebhard LLP Comments on Verdict in Nation’s First Trial Involving Alleged Da Vinci Complications 3Health News:Researchers identify first drug targets in childhood genetic tumor disorder 2
... transplantation reliably yield grafts for two adults? Experts consider ... the July issue of Liver Transplantation , a ... also available online at Wiley Interscience ( www.interscience.wiley.com ). ... advanced surgical strategies to increase opportunities for those in ...
... , ... ROUND ROCK, Texas (Business Wire EON) June 30, ... the mantra that ,more is better, when it comes to managing ... Life Sciences. "Virtualizing the IT infrastructure fully illustrates the idea that ...
... PLANTATION, Fla., June 30 To further growth ... service and,medical management operations, Broadspire has made several ... -- Dennis Replogle, currently chief executive officer, becomes ... currently president of Broadspire, also will,assume the responsibilities ...
... PRUSSIA, Pa., June 30 TMG Health announced,today that ... of the,Ernst & Young Entrepreneur Of The Year(R) 2008 ... the awards program was designed to,recognize outstanding entrepreneurs on ... leading dynamic, growing businesses. Jack Tighe,was selected as a ...
... Declaration Survey, SEOUL, Korea, June 30 ... the workplace and keeping,it top of mind with ... keeping employees safe, according to a DuPont-sponsored survey ... The survey results are the basis for the ...
... FORT WORTH, Texas, June 30 Wound Management,Technologies, ... signing,of a commission based, sales agreement for its ... (EWA GSI). This agreement,follows discussions and demonstrations, and ... role in international wound management.,CellerateRx patented collagen fragments ...
Cached Medicine News:Health News:Experts examine challenges of split liver transplantation 2Health News: Virtualization with Dell Helps Cure Growing Health Care IT Ills 2Health News: Virtualization with Dell Helps Cure Growing Health Care IT Ills 3Health News: Virtualization with Dell Helps Cure Growing Health Care IT Ills 4Health News:Broadspire Announces Key Leadership Appointments 2Health News:Broadspire Announces Key Leadership Appointments 3Health News:TMG Health President and CEO Jack Tighe Named Ernst & Young Entrepreneur Of The Year(R) 2008 in Philadelphia Region 2Health News:TMG Health President and CEO Jack Tighe Named Ernst & Young Entrepreneur Of The Year(R) 2008 in Philadelphia Region 3Health News:Companies Report Success in Driving Safety Culture at Workplaces 2Health News:Companies Report Success in Driving Safety Culture at Workplaces 3Health News:Companies Report Success in Driving Safety Culture at Workplaces 4Health News:Wound Management Technologies, Inc. Announces Sales Agreement with EWA Government Systems, Inc. 2Health News:Wound Management Technologies, Inc. Announces Sales Agreement with EWA Government Systems, Inc. 3
Knot pusher/suture retriever...
Single step suture passage is made simple with Arthro-Pierce instruments. The low profile, highly sharpened tip allows easy passage through tissue in order to retrieve or apply suture....
Arthrex has the most extensive offering of arthroscopic suture passing instruments,available anywhere in the world. We have speci? cally designed the function of our,instruments to work hand in hand ...
Arthrex has the most extensive offering of arthroscopic suture passing instruments,available anywhere in the world. We have speci? cally designed the function of our,instruments to work hand in hand ...
Medicine Products: